Advertisement

Mammalian Cell Mutations

  • C. F. Arlett
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 94 / 2)

Abstract

The importance of in vitro assays of mutation in mammalian cells in the detection and study of carcinogens follows from a consideration of the role of mutation in carcinogenesis. An involvement of mutagenesis is implied from studies of the modulation of oncogenes where G → T transversion in codon 12 of H-ras was seen in the activation of a human oncogene in bladder tumour carcinoma cells (Reddy et al. 1982). Point mutations at other positions within ras genes have also been detected. For example, point mutations at codon 13 have been observed in DNA from patients with acute myeloid leukaemia (Bos et al. 1985). A direct involvement of mutation is seen in studies in which mutations have been analysed in tumours from rodents treated with classical carcinogens. Here codon 12 of the H-ras gene was shown to be altered in mammary tumours induced by nitroso-methylurea in rats (Sukumar et al. 1983). In mouse liver, spontaneous tumours or tumours induced by treatment with furan and furfuranal were analysed (Reynolds et al. 1987). In the spontaneous tumours the activated H-ras mutations were always at codon 61. However, 40%–60% of the ras oncogenes detected in the furan- or furfural-induced tumours were at sites other than codon 61, suggesting that these novel mutations are a reflection of mutagen specificity. Two activated raf genes and four undefined oncogenes were detected in this study.

Keywords

Shuttle Vector Xeroderma Pigmentosum Hprt Gene Mouse Lymphoma Cell Hprt Locus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albertini RJ (1985) Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutation Res 150:411–422PubMedGoogle Scholar
  2. Albertini RJ, Nicklas JA, Sullivan LM, Hunter TC, O’Neill JP (1987) hgprt Mutation in vivo in human T lymphocytes: quantitative considerations. In: Moore MM, De Marini DM, De Serres FJ, Imdall KR (eds) Mammalian cell, mutagenesis. Cold Spring Harbor, pp 139–148 (Banbury Report 28)Google Scholar
  3. Albino AP, Le Strange RL, Oliff AI, Furth ME, Old LJ (1984) Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? Nature 308:69–72PubMedGoogle Scholar
  4. Arita I, Tatsumi I, Tachibana A, Toyoda M, Takebe H (1988) Instability of Mex phenotype in human lymphoblastoid cell lines. Mutation Res 208:167–172PubMedGoogle Scholar
  5. Arlett CF (1977) Mutagenicity testing with Y79 Chinese hamster cells. In: Kilby BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures. Elsevier, Amsterdam, pp 175–192Google Scholar
  6. Arlett CF, Cole J (1986) Mutation studies in cells established from human cancer prone syndromes. In: Ramel C, Lambert B, Magnusson J (eds) Genetic toxicology of environmental chemicals. Part A: principles and mechanisms of action. Liss, New York, pp 237–244Google Scholar
  7. Arlett CF, Cole J (1988) The role of mammalian cell mutation assays in mutagenicity and carcinogenicity testing. Mutagenesis 6:455–458Google Scholar
  8. Arlett CF, Harcourt SA (1982) Variation in response to mutagens amongst normal and repair-defective human cells. In: Lawrence CW (ed) Induced mutagenesis molecular mechanisms and their implications for environmental protection. Plenum, New York, pp 249–266Google Scholar
  9. Arlett CF, Harcourt SA (1983) The mutagen sensitivity response of cells from individuals heterozygous for DNA repair deficiency genes. In: Castellani A (ed) The use of human cells for the evaluation of risk from physical and chemical agents. Plenum, New York, pp 155–167Google Scholar
  10. Arlett CF, Turnbull D, Harcourt SA, Lehmann AR, Colella CM (1975) A comparison of the 8-azaguanine and ouabain resistance systems for the selection of induced mutant Chinese hamster cells. Mutation Res 33:261–278PubMedGoogle Scholar
  11. Ashby J(1986a) Letter to the editor. Mutagenesis 1:309–317PubMedGoogle Scholar
  12. Ashby J (1986b) The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens. Mutagenesis 1:3-l6PubMedGoogle Scholar
  13. Ashman CR, Davidson RL (1984) High spontaneous mutation frequency in shuttle vector sequences recovered from mammalian cellular DNA. Mol Cell Biol 4:2266–2272PubMedGoogle Scholar
  14. Ashman CR, Davidson RL (1985) High spontaneous mutation frequency of BPV shuttle vector. Somatic Cell Mol Genet 11:499–504Google Scholar
  15. Ashman CR, Jagadeeswaran P, Davidson RL (1986) Efficient recovery and sequencing of mutant genes from mammalian chromosomal DNA. Proc Natl Acad Sei USA 83:3356–3368Google Scholar
  16. Baker RM, Brunette DM, MankovitzR, Thompson LH, WhitmoreGF, SiminovitchL, Till TE (1974) Ouabain-resistant mutants of mouse and hamster cells in culture. Cell 1:9–21Google Scholar
  17. Begg AH, Axelman J, Migeon BR (1986) Reactivation of X-linked genes in human fibroblasts transformed by origin-defective SV40. Somatic Cell Mol Genet 12:585–594Google Scholar
  18. Borek C, Ong A, Mason H (1987) Distinctive transforming genes in X-ray-transformed mammalian cells. Proc Natl Acad Sei USA 84:794–798Google Scholar
  19. Bos JL, Toksoz D, Marshall CJ, Verlaan-de Vries M, Veeneman GH, Van Der Eb AJ, Van Boom JH, Janssen WG, Steenvoorden CM (1985) Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 315:726–730PubMedGoogle Scholar
  20. Bradley WEC, Gareau JLP, Seifert AM, Messing K (1987) Molecular characterisation of 15 rearrangements among 90 in vivo somatic mutants shows that deletions predominate. Mol Cell Biol 7:956–960PubMedGoogle Scholar
  21. Bradshaw HD J, Deininger P (1984) Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol Cell Biol 4:2316–2320PubMedGoogle Scholar
  22. Bredberg A, Kraemer KH, Seidman MM (1986) Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells. Proc Natl Acad Sei USA 83:8273–8277Google Scholar
  23. Breimer LH (1988) Ionising radiation-induced mutagenesis. Br J Cancer 57:6–18PubMedGoogle Scholar
  24. Breimer LH, Nalbantoglu J, Meuth M (1986) Structure and sequence of mutations induced by ionizing radiation at selectable loci in Chinese hamster ovary cells. J Mol Biol 192:669–674PubMedGoogle Scholar
  25. Brennand J, Chinault AC, Konecki DS, Melton DW, Caskey CT (1982) Cloned cDNA sequences of the hypoxanthine/guanine phosphoribosyltransferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences. Proc Natl Acad Sei USA 79:1950–1954Google Scholar
  26. Bridges BA (1975) Genetic effects of UV on Escherichia coli -a model for prokaryotes. In: Nygaard OF, Adler HI, Sinclair WK (eds) Radiation research, biomedical, chemical, and physical perspectives. Academic, New York, pp 626–631Google Scholar
  27. Bridges BA (1976) Mutation induction. In: Macdonald KD (ed) Second intern symp genetics of indust microorgs. Academic, LondonGoogle Scholar
  28. Bridges BA (1981) How important are somatic mutations and immune control in skin cancer? Reflections on xeroderma pigmentosum. Carcinogenesis 2:471–472PubMedGoogle Scholar
  29. Bridges BA, Harnden DG (1982) Ataxia-telangiectasia — a cellular and molecular link between cancer, neuropathology and immune deficiency. Wiley, LondonGoogle Scholar
  30. Brown R, Thacker J (1984) The nature of mutants induced by ionising radiation in cultured cells. I. Isolation and initial characterisation of spontaneous, ionising radiation induced, and EMS induced mutants resistant to 6-TG. Mutation Res 129:269–281PubMedGoogle Scholar
  31. Brusick D (1986) Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagen 8:879–886PubMedGoogle Scholar
  32. Calos MP, Lebkowski JS, Botchan MR (1983) High mutation frequency in DNA trans-fected into mammalian cells. Proc Natl Acad Sei USA 80:3015–3019Google Scholar
  33. Cavenee W, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779–784PubMedGoogle Scholar
  34. Clive D, Flamm WG, Machesko MR, Berhnheim NJ (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutation Res 16:77–87PubMedGoogle Scholar
  35. Clive D, Johnson JFS, Spector AG, Batson AG, Brown MM (1979) Validation and characterization of the L5178Y/TK Mouse lymphoma mutagen assay system. Mutat Res 59:61–108PubMedGoogle Scholar
  36. Clive D, Turner N, Krehl R (1988) Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk+/”) locus of mouse lymphoma assay. Mutagenesis 3:83–87PubMedGoogle Scholar
  37. Cole J, Arlett CF (1976) Ethyl methanesulphonate mutagenesis with L5178Y mouse lymphoma cells: a comparison of ouabain, thioguanine and excess thymidine resistance. Mutat Res 34:507–526PubMedGoogle Scholar
  38. Cole J, Arlett CF, Green MHL (1976) The fluctuation test as a more sensitive system for determining induced mutation in L5178 Y mouse lymphoma cells. Mutat Res 41:377–386PubMedGoogle Scholar
  39. Cole J, Arlett CF, Green MHL, Lowe J, Muriel W (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat Res 111:371–386PubMedGoogle Scholar
  40. Cole J, Muriel WJ, Bridges BA (1986) The mutagenicity of sodium fluoride to L5178Y [wild-type and TK +/- (3.7.2C)] mouse lymphoma cells. Mutagenesis 1:157–167PubMedGoogle Scholar
  41. Cox R, Masson WK (1978) Do radiation-induced thioguanine-resistant mutants of cultured mammalian cells arise by HGPRT gene mutation or X-chromosome rearrangement? Nature 276:629–630PubMedGoogle Scholar
  42. Croce CM (1986) Chromosome translocation and human cancer. Cancer Res 46:6019–6023PubMedGoogle Scholar
  43. Davies DR, Evans HJ (1966) The role of genetic damage in radiation induced cell lethality. Adv Radiat Biol 2:243–353Google Scholar
  44. Day RS, Ziolkowsky CHJ, Scudiero DA, Meyer SH, Lubinieck AS, Giradi AJ, Galloway SM, Bynum GD (1980) Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 228:724–727Google Scholar
  45. Dempsey JL, Morley AA (1986) Measurement of in vivo mutant frequency in lymphocytes in the mouse. Environ Mutagen 8:385–391PubMedGoogle Scholar
  46. Drinkwater N, Klinedinst DK (1986) Chemically induced mutagenesis in a shuttle vector with a low background mutant frequency. Proc Natl Acad Sei USA 83:3402–3406Google Scholar
  47. Drobetsky EA, Grosovsky AJ, Glickman BW (1987) The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc Natl Acad Sei USA 84:9103–9107Google Scholar
  48. DuBridge R, Tang P, Hsia HC, Leong P-M, Miller JH, Calos MP (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7:379–387PubMedGoogle Scholar
  49. DuBridge RB, Calos MP (1988) Recombinant shuttle vectors for the study of mutation in mammalian cells. Mutagenesis 3:1–10PubMedGoogle Scholar
  50. Ennever FK, Noonan TJ, Rosenkranz HS (1987) The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. Mutagenesis 2:73–78PubMedGoogle Scholar
  51. Evans HJ (1988) Mutation cytogenetics: past, present and future. Mutat Res 204:355–363PubMedGoogle Scholar
  52. Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM (1987) A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330:386–391PubMedGoogle Scholar
  53. Fox M, Radacic M (1978) Adaptational origin of some purine-analogue resistant phenotypes in cultured mammalian cells. Mutat Res 49:275–296PubMedGoogle Scholar
  54. Fuscoe JC, Fenwick JRG, Ledbetter DH, Caskey CT (1983) Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol 3:1086–1096PubMedGoogle Scholar
  55. Fuscoe JC, Ockey CH, Fox M (1986) Molecular analysis of X-ray-induced mutants at the HPRT locus in V79 Chinese hamster cells. Int J Radiat Biol 49:1011–1020Google Scholar
  56. Garner RC, Kirkland DJ (1986) Reply. Mutagenesis 1:233–235Google Scholar
  57. Gatehouse DG, Tweats DJ (1986) Letter to the editor. Mutagenesis 1:307–308PubMedGoogle Scholar
  58. Gebara MM, Drevon C, Harcourt SA, Steingrimsdottir H, James MR, Burke JF, Arlett CF, Lehmann AR (1987) Inactivation of a transfected gene in human fibroblasts can occur by deletion, amplification, phenotypic switching, or methylation. Mol Cell Biol 7:1459–1464PubMedGoogle Scholar
  59. Gey GO, Coffman WD, Kubicek WT (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:264–265Google Scholar
  60. Gibbs RA, Caskey CT (1987) Molecular analysis of human hprt mutations. In: Moore MM, De Marini DM, De Serres FJ, Tindali KR (eds) Mammalian cell mutagenesis. Banbury Report 28, Cold Spring Harbor, pp 237–247Google Scholar
  61. Glazer PM, Sarkar SN, Summers WC (1986) Detection and analysis of UV-induced mutations in mammalian cell DNA using a lambda phage shuttle vector. Proc Nat Acad Sci USA 83:1041–1044PubMedGoogle Scholar
  62. Glickman BW, Drobetsky EA, Grososvsky AJ (1987) A study of the specificity of spontaneous and UV-induced mutation at the endogenous aprt gene of Chinese hamster overy cells. In: Moore MM, De Marini DM, De Serres FJ, Tindall KR (eds) Mammalian cell mutagenesis. Banbury Report 28, Cold Spring Harbor, pp 167–182Google Scholar
  63. Green MHL, Lowe JE, Arlett CF, Harcourt SA, Burke JF, James MR, Lehmann AR, Povey SM (1987) A gamma-ray resistant derivative of an ataxia-telangiectasia cell line obtained following DNA-mediated gene transfer. J Cell Sci [Suppl] 6:127–137Google Scholar
  64. Grosovksy AJ, Drobetsky EA, De Jong PJ, Glickman BW (1986) Southern analysis of genomic alterations in gamma ray induced APRT” hamster cell mutants. Genetics 113:405–415Google Scholar
  65. Harris M (1973) Anomalous patterns of mutation in cultured mammalian cells. Genetics 73:181–185Google Scholar
  66. Hauser J, Seidman MM, Sidur K, Dixon K (1986) Sequence specificity of point mutations induced during passage of a UV-irradiated shuttle vector plasmid in monkey cells. Mol Cell Biol 6:277–285PubMedGoogle Scholar
  67. Hauser J, Levine AS, Dixon K (1987) Unique pattern of point mutations arising after gene transfer into mammalian cells. EMBO J 6:63–67PubMedGoogle Scholar
  68. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621Google Scholar
  69. Henderson EE, Ribecky R (1980) DNA repair in lymphoblastoid cell lines established from human genetic disorders. Chem Biol Interact 33:63–82PubMedGoogle Scholar
  70. Henderson L, Cole H, Cole J, James SE, Green MHL (1986) Detection of somatic amuta-tions in man: evaluation of the microtiter cloning assay for T-lymphocytes. Mutagenesis 1:195–200PubMedGoogle Scholar
  71. Hoar DI (1975) Phenotypic manifestations of ataxia-telangiectasia. Lancet ii:1048Google Scholar
  72. Hogan B, Fellous M, Avner P, Jacob F (1977) Isolation of a human teratoma cell line which expresses F9 antigen. Nature 270:515–518PubMedGoogle Scholar
  73. Howell JN, Greene MH, Corner RC, Maher VM, MeCormick J J (1984) Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline-l-oxide. Proc Natl Acad Sci USA 81:1179–1183PubMedGoogle Scholar
  74. Hozier J, Sawyer J, Clive D, Morre M (1985) Chromosome 11 aberrations in small colony L5178Y -/- mutants early in their clonal history. Ann NY Acad Sci 107:423–125Google Scholar
  75. Huschtscha LI, Holliday R (1983) Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci 63:77–99PubMedGoogle Scholar
  76. Ishidate M Jr, Harnois MC (1987) The clastogenicity of chemicals in cultured mammalian cells. Letter to the editor. Mutagenesis 2:240–243PubMedGoogle Scholar
  77. Ishidate MJ (1983) The data book of chromosomal aberration tests in vitro. Realize, TokyoGoogle Scholar
  78. Janatipour M, Trainor KJ, Kutlaca R, Bennett G, Hay J, Turner DR, Morley AA (1988) Mutations in human lymphocytes studied by an HLA selection system. Mutat Res 198:221–226PubMedGoogle Scholar
  79. Jolly DJ, Okayama H, Berg P, Esty AC, Filpula D, Bohlen P, Johnson GG, Shively JE, Hunkapillar T, Friedmann T (1983) Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci USA 80:477–481PubMedGoogle Scholar
  80. Jones IM, Burkhart-Schultz K, Crippen TL (1987 a) Cloned mouse lymphocytes permit analysis of somatic mutations that occur in vivo. Somatic Cell Mol Genet 13:325–333Google Scholar
  81. Jones IM, Burkhart-Schultz K, Strout CL, Crippen TL (1987b) Factors that affect the frequency of thioguanine-resistant lymphocytes in mice following exposure to ethyl- nitrosourea. Environ Mutagen 9:317–329PubMedGoogle Scholar
  82. Kavathas P, Bach FH, DeMars R (1980) Gamma ray-induced loss of expression of HLA and glyoxalase 1 alleles in lymphoblastoid cells. Proc Natl Acad Sci USA 77:4251–4255PubMedGoogle Scholar
  83. Kelly WN, Wyngaarden JB (1983) Clinical syndromes associated with hypoxanthine- guanine phosphoribosyltransferase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 1115–1143Google Scholar
  84. King HWS, Brookes P (1984) On the nature of mutations induced by the diolepoxide of benzo(a)pyrene in mammalian cells. Carcinogenesis 5:965–970PubMedGoogle Scholar
  85. Koneeki DS, Brennand J, Fuscoe JC, Caskey CT, Chinault AC (1982) Hypoxanthine- guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res 10:6753–6775Google Scholar
  86. Koufos A, Hansen MF, Copeland N, Jenkins NA, Lampkin BC, Cavenee WK (1985) Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 316:330–334PubMedGoogle Scholar
  87. Kraemer KH (1980) Xeroderma pigmentosum. In: Demis DJ, Dobson RL, McGuire J (eds) Clinical dermatology, vol 4. Harper and Row, Hagerstown, pp 1–33Google Scholar
  88. Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250PubMedGoogle Scholar
  89. Lambert B, Chu EHY, De Carli L, Ehling UH, Evans HJ, Hayashi M, Thilly WG, Vainio H (1986) Assays for genetic changes in mammalian cells. I ARC Sci Publ 83:167–243Google Scholar
  90. Langlois RG, Bigbee WL, Kyoizumi S, Nakamura N, Bean MA, Akiyama M, Jensen RH (1987) Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science 236:445–448PubMedGoogle Scholar
  91. Lehmann AR (1987) Cockayne’s syndrome and trichothiodystrophy: defective repair without cancer. Cancer Rev 7:82–103Google Scholar
  92. Liber HL, Leong PK, Terry VH, Little JB (1986) X-rays mutate human lymphoblast cells at genetic loci that should respond only to point mutagens. Mutat Res 163:91–97PubMedGoogle Scholar
  93. Lowy I, Pellicer A, Jackson JF, Sim G-K, Silverstein S, Axel R (1980) Isolation of transforming DNA: cloning the hamster aprt gene. Cell 22:817–823PubMedGoogle Scholar
  94. MacGregor GR, Burke JF (1987) Stability of a bacterial gene in a bovine papilloma virus- based shuttle vector maintained extrachromosomally in mammalian cells. J Gen Virol 68:247–252PubMedGoogle Scholar
  95. MacGregor GR, James MR, Arlett CF, Burke JF (1987) Analysis of mutations occurring during replication of a SV40 shuttle vector in mammalian cells. Mutat Res 183: 273–278PubMedGoogle Scholar
  96. Marshall CJ, Vousden KM, Phillips DM (1984) Activation of c-Ha-ras-l proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide. Nature 310:586–589PubMedGoogle Scholar
  97. Masters JRW, Hepburn PJ, Walker L, Highman W, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR, Franks LM (1986) Tissue culture model of transitional cell carcinoma: characterisation of twenty-two human urothelial cell lines. Cancer 46: 3630–3636Google Scholar
  98. Mathew CGP, Smith BA, Thorpe K, Wong K, Royle NJ, Jeffreys AJ, Ponder BAJ (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328:524–526PubMedGoogle Scholar
  99. Mayne LV, Priestley A, James MR, Burke JF (1986) Efficient immortalization and morphological transformation of human fibroblasts by transfection with SV40 DNA linked to a dominant marker. Exp Cell Res 162:530–538PubMedGoogle Scholar
  100. McGregor D, Riach C, Cattanach P, Caspary W (1987) Development and investigation of an expanded CHO/hgprt locus assay. Mutagenesis 2:303Google Scholar
  101. Messing K, Bradley WEC (1985) In vivo mutant frequency rises among breast cancer patients after exposure to high doses of gamma-irradiation. Mutat Res 152:107–112PubMedGoogle Scholar
  102. Meuth M, Arrand JE (1982) Alterations of gene structures in EMS-induced mutants of mammalian cells. Mol Cell Biol 2:1459–1462PubMedGoogle Scholar
  103. Meuth M, Nalbantoglu J, Phear G, Miles C (1987) Molecular basis of genome rearrangements at the hamster aprt locus. In: Moore MM, De Marini DM, De Serres FJ, Tindall KR (eds) Mammalian cell mutagenesis. Banbury Report 28, Cold Spring Harbor, pp 183–191Google Scholar
  104. Mitchell PJ, Urlaub G, Chasin L (1986) Spontaneous splicing mutations at the dihydrofo- late reductase locus in Chinese hamster ovary cells. Mol Cell Biol 6:1926–1935PubMedGoogle Scholar
  105. Montesano R, Bartsch H, Vainio H, Wilbourn J, Yamasaki H (1986) Long-term and short-term assays for carcinogens: a critical appraisal. IARC Sci Publ 83. IARC, LyonGoogle Scholar
  106. Moore MM, Clive D, Howard BE, Batson AG, Turner NT (1985a) In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/_ mouse lymphoma cells. Mutat Res 151:147–159PubMedGoogle Scholar
  107. Moore MM, Clive D, Hozier JC, Howard BE, Batson AG, Turner NT, Sawyer J (1985b) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells. Mutat Res 151:161–174PubMedGoogle Scholar
  108. Moore MM, De Marini DM, De Serres FJ, Tindall KR (1987) Mammalian cell mutagenesis. Banbury Report 28:1–385Google Scholar
  109. Morison WL, Bucana C, Hashem N, Kripke ML, Cleaver JE, German JL (1985) Impaired immune function in patients with xeroderma pigmentosum. Cancer Res 45:3929–3931PubMedGoogle Scholar
  110. Morley AA, Trainor KJ, Dempsey JL, Seshadri RS (1985) Methods for study of mutations and mutagenesis in human lymphocytes. Mutat Res 147:363–367PubMedGoogle Scholar
  111. Morrell D, Cromartie E, Swift M (1986) Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. JNCI 77:89–92PubMedGoogle Scholar
  112. Murnane JP, Fuller LF, Painter RB (1985) Establishment and characterization of a permanent pSV ori~-transformed ataxia-telangiectasia cell line. Exp Cell Res 158:119–126PubMedGoogle Scholar
  113. Nadon N, Sekhon G, Brown LJ, Korn N, Petersen JW, Strandtmann J, Chang C, DeMars R (1986) Derepression of HPRT locus on inactive X chromosome of human lymphoblastoid cell line. Somatic Cell Mol Genet 12:541–554Google Scholar
  114. Nalbantoglu J, Goncalves O, Meuth M (1983) Structure of mutant alleles at the aprt locus of CHO cells. J Mol Biol 167:575–594PubMedGoogle Scholar
  115. Nalbantoglu J, Phear G, Meuth M (1987) DNA sequence analysis of spontaneous mutations at the aprt locus of hamster cells. Mol Cell Biol 7:1445–1449PubMedGoogle Scholar
  116. Nicklas JA, O’Neill JP, Albertini RJ (1986) Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. Mutat Res 173:67–72PubMedGoogle Scholar
  117. Padua RA, Barrass N, Currie GA (1984) A novel transforming gene in a human malignant melanoma cell line. Nature 311:671–673PubMedGoogle Scholar
  118. Paeratakul U, Taylor MW (1986) Isolation and characterisation of mutants at the APRT locus in the L-5178Y TK+/TK” mouse lymphoma cell line. Mutat Res 160:61–69PubMedGoogle Scholar
  119. Patel PI, Framson PE, Caskey CT, Chinault AC (1986) Fine structure mapping of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol 6:393–403PubMedGoogle Scholar
  120. Perera MIR, Um KI, Grenne MH, Waters HL, Bredberg A, Kraemer KH (1986) Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility. Cancer Res 4:1005–1009Google Scholar
  121. Pippard EC, Hall AJ, Barker DJP, Bridges BA (1988) Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929–2933PubMedGoogle Scholar
  122. Povey S, Gardiner SE, Watson B, Mowbray S, Harris H, Arthur E, Steel CM, Blenkinsop C, Evans HJ (1973) Genetic studies on human lymphoblastoid lines: isozyme analysis on cell lines from forty-one different individuals and on mutants produced following exposure to a chemical mutagen. Ann Hum Genet 36:247–266PubMedGoogle Scholar
  123. Puck TT, Waldren CA (1987) Mutation in mammalian cells: theory and implications. Somatic Cell Mol Genet 13:405–409Google Scholar
  124. Razzaque A, Mizusawa H, Seidman M (1983) Rearrangement and mutagenesis of a shuttle vector plasmic after passage in mammalian cells. Proc Natl Acad Sci USA 80:3010–3014PubMedGoogle Scholar
  125. Razzaque A, Chakrabarti S, Joffee S, Seidman M (1984) Mutagenesis of a shuttle vector plasmid in mammalian cells. Mol Cell Biol 4:435–441PubMedGoogle Scholar
  126. Reddy EP, Reynolds RK, Santos E, Barbacid M (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300:149–152PubMedGoogle Scholar
  127. Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW (1987) Activated oncogenes in B6C3F1 mouse liver tumours: implications for risk assessment. Science 237:1309–1316PubMedGoogle Scholar
  128. Rogers AM, Hill R, Lehmann AR, Arlett CF, Burns VW (1980) The induction and characterization of mouse lymphoma L5178Y cell lines resistant to l-/?-D-arabinofura- nosyl-cytosine. Mutat Res 69:139–148PubMedGoogle Scholar
  129. Rosenkranz HS (1988) Strategies for the deployment of batteries of short-term tests. Mutat Res 205:1–426Google Scholar
  130. Rouleau GA, Wertelecki W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger BR, Martuza RL, Superneau DW, Conneally PM, Gusella JF (1987) Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246–248PubMedGoogle Scholar
  131. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985) Enzymatic amplification of B-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354PubMedGoogle Scholar
  132. Sanderson BJS, Dempsey JL, Morley AA (1984) Mutations in human lymphocytes: effect of X- and UV-irradiation. Mutat Res 140:223–227PubMedGoogle Scholar
  133. Sarkar S, DasGupta UB, Summers WC (1984) Error-prone mutagenesis detected in mammalian cells by a shuttle vector containing the supF gene of Escherichia coli. Mol Cell Biol 4:2227–2230PubMedGoogle Scholar
  134. Seetharam S, Protic-Sabljic M, Seidman MM, Kraemer KH (1987) Abnormal ultraviolet mutagenic spectrum in plasmid DNA replicated in cultured fibroblasts in a patient with the skin cancer-prone disease, xeroderma pigmentosum. J Clin Invest 80:1613–1617PubMedGoogle Scholar
  135. Seidman MM, Dixon K, Razzaque A, Zagursky RJ, Berman ML (1985) A shuttle vector plasmic for studying carcinogen-induced point mutations in mammalian cells. Gene 38:233–237PubMedGoogle Scholar
  136. Shiloh Y, Tabor E, Becker Y (1982a) The response of ataxia-telangiectasia homozygous and heterozygous skin fibroblasts to neocarzinostatin. Carcinogenesis 3:815–820PubMedGoogle Scholar
  137. Shiloh Y, Tabor E, Becker Y (1982b) Colony-forming ability of ataxia-telangiectasia skin fibroblasts is an indicator of their early senescence and increased demand for growth factors. Exp Cell Res 140:191–199PubMedGoogle Scholar
  138. Simons JWIM (1982) Studies on survival and mutation in ataxia-telangiectasia cells after X-irradiation under oxic and anoxic conditions. In: Bridges BA, Harnden DG (eds) Ataxia-telangiectasia — cellular and molecular link between cancer, neuropathology and immune deficiency. Wiley, Chichester, pp 165–167Google Scholar
  139. Simpson NE, Kidd KK, Goodfellow PJ, McDermic H, Myers S, Kidd JR, Jackson CE, Duncan AMV, Farrer LA, Brasch K, Castiglione C, Genel M, Gertner J, Greenberg CR, Gusella JF, Holden J J A, White BN (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328:528–530PubMedGoogle Scholar
  140. Skulimowski AW, Turner DR, Morley AA, Sanderson BJS, Haliandros M (1986) Molecular basis of X-ray-induced mutation at the HPRT locus in human lymphocytes. Mutat Res 162:105–112PubMedGoogle Scholar
  141. Smith PJ, Greene MH, Devlin DA, McKeen EA, Paterson M (1982) Abnormal sensitivity to UV-radiation in cultured skin fibroblasts from patients with hereditary cutaneous malignant melanoma and dysplastic nevus syndrome. Int J Cancer 30:39–45PubMedGoogle Scholar
  142. Smith PJ, Greene MH, Adams D, Paterson M (1983) Abnormal responses to the car-cinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma. Carcinogenesis 4:911–916PubMedGoogle Scholar
  143. Stamatoyannopoulos GP, Nute E, Lindsley D, Farquhar M, Brice M, Nakamoto N, Papayannopoulu T (1984) Somatic-cell mutation monitoring system based on human hemoglobin mutants. In: Ansari A A, de Serres FJ (eds) Single-cell mutation monitoring systems, methodologies and applications. Plenum, New York, pp 1–29 (Topics in chemical mutagenesis 2)Google Scholar
  144. Stefanini M, Lagomarsini P, Arlett CF, Marinoni S, Borrone C, Crovato F, Trevisan G, Cordone G, Nuzzo F (1986) Xeroderma pigmentosum (complementation group D) mutation is present in patients affected by trichothiodystrophy with photosensitivity. Hum Genet 74:107–112PubMedGoogle Scholar
  145. Stefanini M, Lagomarsini P, Giorgi R, Nuzzo F (1987) Complementation studies in cells from patients affected by trichothiodystrophy with normal or enhanced photosensitivity. Mutat Res 191:117–119PubMedGoogle Scholar
  146. Strong LC, Riccardi VM, Ferrell RE, Sparkes RS (1981) Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science 213:1501–1503PubMedGoogle Scholar
  147. Sugden B, Marsh K, Yates J (1985) A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol 5:410–413PubMedGoogle Scholar
  148. Sukumar S, Notario V, Martin-Zanca D, Barbacid M (1983) Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-l locus by single point mutations. Nature 306:658–661PubMedGoogle Scholar
  149. Swift M, Reitnauer PJ, Morrel D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289–1294PubMedGoogle Scholar
  150. Tatsumi K, Takebe H (1984) Gamma-irradiation induces mutation in ataxia-telangiectasia lymphoblastoid cells. Gann 75:1040–1043PubMedGoogle Scholar
  151. Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236:933–941PubMedGoogle Scholar
  152. Teo I A, Lehmann AR, Muller R, Rajwesky MF (1983) Similar rate of 06-ethylguanine elimination from DNA in normal human fibroblast and xeroderma pigmentosum cell strains not transformed by SV40. Carcinogenesis 4:1075–1077PubMedGoogle Scholar
  153. Thacker J (1986) The nature of mutants induced by ionising radiation in cultured hamster cells. III. Molecular characterisation of HPRT-deficient mutants induced by gamma rays or alpha particles showing that the majority have deletions of all or part of the hprt gene. Mutat Res 160:267–275PubMedGoogle Scholar
  154. Thacker J, Stephens MA, Stretch A (1978) Mutation to ouabain resistance in Chinese hamster cells: induction by ethyl methanesulphonate and lack of induction by ionising radiation. Mutat Res 51:255–270PubMedGoogle Scholar
  155. Thilly WG, DeLuca JG, Furth EE, Hoppe H IV, Kaden DA, Krolewski JJ, Liber HL, Skopek TR, Slapikoff SA, Tizard RJ, Penman BW (1980) Gene-locus mutation assays in diploid human lymphoblast lines. In: de Serres FJ, Hollaender A (eds) Chemical mutagens, vol 6. Plenum, New York, pp 331–364Google Scholar
  156. Tindali KR, Stankowski LF, Machanoff R, Hsie AW (1986) Analyses of mutation in pSV2gpt-transformed cells. Mutat Res 160:121–131Google Scholar
  157. Todd PA, Glickman BW (1982) Mutational specificity of uv light in E. coli: indications for a role for DNA secondary structure. Proc Natl Acad Sei USA 79:4123–127Google Scholar
  158. Turner DR, Morley AA, Haliandros AA, Kutlaca R, Sanderson BJ (1985) In vivo somatic mutations in human lymphocytes frequently result from major gene alterations. Nature 315:343–345PubMedGoogle Scholar
  159. Tweats DJ, Gatehouse DG (1988) Further debate of testing strategies. Mutagenesis 3:95–102PubMedGoogle Scholar
  160. Urlaub G, Kas E, Carothers AM, Chasin LA (1983) Deletions of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 33:405PubMedGoogle Scholar
  161. Urlaub G, Carothers AM, Chasin LA (1985) Efficient cloning of single-copy genes using specialised cosmid vectors: Isolation of mutant dehydrofolate reductase genes. Proc Natl Acad Sei USA 82:1189–1193Google Scholar
  162. Van Zeeland AA, Van Diggelen MCE, Simons JWIM (1972) The role of metabolic cooperation in selection of hypoxanthine-guanine-phosphoribosyl-transferase (HG- PRT)deficient mutants from diploid mammalian cell strains. Mutat Res 14:355–363Google Scholar
  163. Verwoerd NP, Bernini LF, Bonnet J, Tanke HJ, Natarajan AT, Tates AD, Sobels FH, Ploem JS (1987) Somatic cell mutations in humans detected by image analysis of im- munofluorescently stained erythrocytes. In: Burger G, Ploem JS, Goerttler K (eds) Clinical cytometry and histometry. Academic, London, pp 465–469Google Scholar
  164. Vrieling H, Simons JWIM, Arwert F, Natarajan AT, Van Zeeland AA (1985) Mutations induced by X-rays at the hprt locus in Chinese hamster cells are mostly large deletions. Mutat Res 144:281–286PubMedGoogle Scholar
  165. Wagenheim J, Bolesfoldi G (1988) Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis 3:193–205Google Scholar
  166. Waldmann TA, Misiti J, Nelson DL, Kraemer KH (1983) Ataxia-telangiectasia: a multi-system hereditary disease with immunodeficiency, impaired organ maturation, X-ray hypersensitivity, and a high incidence of neoplasia. Ann Intern Med 99:367–379Google Scholar
  167. Waldren C, Correll L, Sognier MA, Puck TT (1986) Measurement of low levels of X-ray mutagenesis in relation to human disease. Proc Natl Acad Sei USA 83:4839–4843Google Scholar
  168. Waldren CA, Puck TT (1987) Steps toward experimental measurement of total mutations relevant to human disease. Somatic Cell Mol Genet 13:411–414Google Scholar
  169. Wilson JM, Young AB, Kelley WN (1983) Hypoxanthine-guanine phosphoribosyltrans- ferase deficiency. The molecular basis of the clinical syndrome. N Engl J Med 309:900–910PubMedGoogle Scholar
  170. Wilson JM, Stout JT, Palella TD, Davidson BL, Kelley WN, Caskey CT (1986) A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. J Clin Invest 77:188–195PubMedGoogle Scholar
  171. Yandell DW, Dryja TP, Little JB (1986) Somatic mutation at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations. Somatic Cell Mol Genet 12:255–263Google Scholar
  172. Yang TP, Patel PI, Chinault AC, Stout JT, Jackson LG, Hildebrand BM, Caskey CT (1984) Molecular evidence for new mutations at the hprt locus in Lesch-Nyhan patients. Nature 310:412–414PubMedGoogle Scholar
  173. Yates J, Warren N, Reisman D, Sugden B (1984) A ds-acting element from the Epstein- Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sei USA 81:3806–3810Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • C. F. Arlett

There are no affiliations available

Personalised recommendations